
Our People

Stefan Jovinge MD, PhD
Co-founder
Dr. Jovinge is a global thought leader in regenerative medicine, cardiovascular health, and rare diseases. His laboratory developed the technologies that are the foundation of Intent Pharmaceuticals. His research has graced the pages of leading international journals, and he is a highly respected research leader both in the United States and Europe.
Jens Forsberg PhD
Co-founder
Dr. Forsberg has over two decades of experience in biomedical research, with experience ranging from transcriptomics and proteomics to structural biology. In addition, Dr. Forsberg brings extensive experience in project management, grant writing, and project design.


Eric J. Kort MD, MS
Co-founder
Dr. Kort brings more than 20 years of experience in bioinformatics and computational biology. He has authored dozens of papers in the field, as well as multiple software packages facilitating analysis of gene expression data. He is also a practicing physician with extensive clinical experience and expertise. He spear-headed the development of the technologies at the core of Intent Pharmaceuticals.